Parvin Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-25
Closed -$948 356
2024
Q4
$948 Buy
+25
New +$998 ﹤0.01% 317

Other funds holding BME

Parvin Asset Management's BME Position: Q1 2025 in Review

Parvin Asset Management sold out of BlackRock Health Sciences Trust (BME) in Q1 2025, closing a stake of 25 shares — an estimated $948 sold.

Parvin Asset Management first reported a position in BME in Q4 2024 and held it in 1 quarter. The position peaked at $948 in Q4 2024. 67 funds tracked by Wall St. Rank hold BME as of Q1 2025.

  • Parvin Asset Management reported no remaining BlackRock Health Sciences Trust position as of Q1 2025 after selling out during the quarter.
  • Parvin Asset Management sold 25 BlackRock Health Sciences Trust shares in Q1 2025, an estimated $948.
  • Parvin Asset Management first reported a position in BlackRock Health Sciences Trust in Q4 2024 and held it in 1 quarter.
  • Parvin Asset Management's BlackRock Health Sciences Trust position peaked at $948 in Q4 2024.
  • 67 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2025.

Based on Parvin Asset Management's 13F filing for Q1 2025, filed 15 May 2025.